BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND KDM5C, XE169, SMCX, JARID1C, 8242, ENSG00000126012, DXS1272E, MRXSJ, MRXJ, RP11-258C19_2 AND Treatment
14552 results:

  • 1. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
    Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Wu Y; Jiang P; Chen Z; Li W; Dong B; Zhang Y
    BMC Cancer; 2024 May; 24(1):589. PubMed ID: 38745137
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FIGO 2023 endometrial staging: a leap of faith into the new "prognostic based' rather than "anatomical based" staging-too fast too furious??
    Bassetty KC; Begum D; Barmon D; Baruah U; Gupta S; Kumar M; Nath J; Khanikar D; Bhattacharyya M; Roy PS
    J Cancer Res Clin Oncol; 2024 May; 150(5):251. PubMed ID: 38733417
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
    J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
    J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Histological assessment of endometrial polyps resected by hysteroscopy.
    Tekin S; Ocal A; Sisman E; Bilginer C; Cetin A
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3241-3250. PubMed ID: 38708482
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
    Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
    Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
    Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
    Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
    PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metformin for endometrial hyperplasia.
    Shiwani H; Clement NS; Daniels JP; Atiomo W
    Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y; Wang W; Tang J; Hu K; Zhang F
    BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
    Huang Y; Zhou S; Su Y; Pang Z; Cai S
    Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
    Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
    Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical Significance of Serum SCC Levels Before treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
    Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
    Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reproductive Outcomes in Young Women with Early-Stage Cervical cancer Greater than 2 cm Undergoing Fertility-Sparing treatment: A Systematic Review.
    D'Amato A; Riemma G; Agrifoglio V; Chiantera V; Laganà AS; Mikuš M; Dellino M; Maglione A; Faioli R; Giannini A; Trojano G; Etrusco A
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674254
    [No Abstract]    [Full Text] [Related]  

  • 18. The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.
    Buchynska L; Gordiienko I; Glushchenko N; Iurchenko N
    PLoS One; 2024; 19(4):e0302075. PubMed ID: 38669256
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical cancer Cells.
    Mehta H; Ambele MA; Mokgautsi N; Moela P
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
    Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
    Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 728.